The biologic treatment missed the primary endpoint, but did show some improvements in those given the drug and may be better ...

Mesoblast has received FDA approval for Ryoncil, becoming the first and only cell therapy of its kind to be available in the ...

The anti-TL1A antibody allowed significantly more inflammatory bowel disease (IBD) patients to go into remission than those ...

The Swedish pharma company Orexo and biotech firm Abera Bioscience announced today that they have joined forces to develop ...

The acquisition will grant Roche full ownership over a pipeline of allogeneic CAR-T therapy candidates, including two oncology programs it had previously in-licensed. Roche and Poseida Therapeutics ...

The Danish biotech company Antag Therapeutics announced yesterday that it had raised €80 million ($84 million) in a Series A financing round to boost the clinical development of its next-generation ...

The partnership revolves around Muna Therapeutics’ technology platform, which employs a spatial multi-omics approach to identify and validate new drug targets for neurodegenerative diseases. GSK and ...